NCT03096925

Brief Summary

This study aims to test an easily implementable web-based cognitive behaviour therapy (CBT) self-help intervention designed for non-cardiac chest pain patients, and compare effectiveness and cost-effectiveness to treatment as usual in an randomized controlled trial (RCT).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 30, 2017

Completed
4 days until next milestone

Study Start

First participant enrolled

April 3, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2019

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

February 1, 2023

Status Verified

January 1, 2023

Enrollment Period

2.7 years

First QC Date

February 16, 2017

Last Update Submit

January 31, 2023

Conditions

Keywords

non-cardiac chest painanxiety

Outcome Measures

Primary Outcomes (2)

  • Change in Cardiac Anxiety Questionnaire (CAQ)

    CAQ is an 18-item self-report-questionnaire which measures hearth related anxiety/fear, attention, avoidance and safety seeking behavior. Each item is rated on a five-point Likert scale ranging from 0 to 4. Total range 0-72 where higher score represents more symptoms. Primary outcome is difference in mean score between intervention arm and control arm for CAQ at end of treatment (6 weeks after randomization for both arms). Difference in mean scores between arms will also be assessed at pretreatment/baseline, and at 3 months and 12 months after end of treatment (18 weeks and 58 weeks after randomization). There is no predefined clinical relevant effect for this measure, we use a distribution based method and define clinical relevant effect as improvement of more than 0.5 standard deviation compared to baseline.

    58 weeks

  • Change in Body Sensations Questionnaire (BSQ)

    BSQ is an 17-item self-report-questionnaire which measures fear of different bodily sensations. Each item is rated on a five-point Likert scale ranging from 1 to 5. Total range 17-85 where higher score represents more symptoms. Primary outcome is difference in mean score between intervention arm and control arm for BSQ at end of treatment (6 weeks after randomization for both arms). Difference in mean scores between arms will also be assessed at pretreatment/baseline, and at 3 months and 12 months after end of treatment (18 weeks and 58 weeks after randomization). There is no predefined clinical relevant effect for this measure, we use a distribution based method and define clinical relevant effect as improvement of more than 0.5 standard deviation compared to baseline.

    58 weeks

Secondary Outcomes (5)

  • Change in Brief Illness Perception Questionnaire (BIPQ)

    58 weeks

  • Change in Patient Health Questionnaire (PHQ-9)

    58 weeks

  • Change in General perceived Self-Efficacy Scale

    58 weeks

  • Change in EQ-5D-5L

    58 weeks

  • Health care costs

    58 weeks

Other Outcomes (1)

  • Composite measures

    58 weeks

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive guided self-help comprising six web-based sessions, comprising information, exposure to physical activity, how worry can excess pain, physical reactions to pain and worry, consequences of avoidance, and specific panic treatment. The first session will be done at the hospital before discharge, the others at home. Between sessions there will be a brief telephone contact with a project worker.

Behavioral: Guided self-help

Control group

NO INTERVENTION

This group will receive treatment as usual, which is no specific treatment. They can however use the general health system as they like.

Interventions

Web-based guided self-help intervention

Intervention group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-Cardiac Chest Pain

You may not qualify if:

  • Language difficulties
  • Unable to perform at least moderate physical activity due to physical constraints
  • Obvious cognitive impairment (e.g mentally retarded, psychotic, dementia or intoxicated)
  • no regular access to a computer/tablet computer with internet connection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sorlandet Sykehus HF

Kristiansand, Vest Agder, 4604, Norway

Location

Related Publications (2)

  • Thesen T, Himle JA, Pripp AH, Sunde T, Walseth LT, Thorup F, Gallefoss F, Jonsbu E. Patients with depression symptoms are more likely to experience improvements of internet-based cognitive behavioral therapy: a secondary analysis of effect modifiers in patients with non-cardiac chest pain in a randomized controlled trial. BMC Psychiatry. 2023 Oct 14;23(1):751. doi: 10.1186/s12888-023-05238-1.

  • Thesen T, Himle JA, Martinsen EW, Walseth LT, Thorup F, Gallefoss F, Jonsbu E. Effectiveness of Internet-Based Cognitive Behavioral Therapy With Telephone Support for Noncardiac Chest Pain: Randomized Controlled Trial. J Med Internet Res. 2022 Jan 24;24(1):e33631. doi: 10.2196/33631.

MeSH Terms

Conditions

Chest PainAnxiety Disorders

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Frode Gallefoss, MD, PhD

    Head of Clinical Research, Sørlandet HF.

    STUDY DIRECTOR
  • Liv T Walseth, MD, PhD

    Researcher, Sørlandet HF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible patients will be consecutively included and randomized to two groups, intervention group or control group. We will use a web-based randomisation procedure, conducted at a place remote from where the study takes place.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2017

First Posted

March 30, 2017

Study Start

April 3, 2017

Primary Completion

December 19, 2019

Study Completion

January 1, 2024

Last Updated

February 1, 2023

Record last verified: 2023-01

Locations